Clinical Trials Browser

Terminated × Small Cell Lung Carcinoma × rovalpituzumab tesirine × Clear all

NCT03033511 2021-07-29

MERU

Phase 3 Terminated

748 enrolled 13 charts

Neoplasms, Small Cell Lung Carcinoma

NCT03026166 2020-07-17

A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer

Phase 1/2 Terminated

42 enrolled 15 charts

Neoplasms, Small Cell Lung Carcinoma

NCT02819999 2020-03-12

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Phase 1 Terminated

Small Cell Lung Carcinoma